An affiliate of Balmoral Funds LLC (“Balmoral”) has acquired Wilbur-Ellis Nutrition, LLC (“Nutrition” or the “Company” or “Rangen”), a leading provider of custom nutrition products in Pet, Aquaculture and Livestock markets, from Wilbur-Ellis Holdings II, LLC (“Wilbur-Ellis”). Going forward, Nutrition will operate under the name Rangen, a historic brand that many of its customers are already familiar with.

The transaction covers the full Nutrition business of Wilbur-Ellis, including the Rangen, Ametza, Emmert, Oxy-Gon, Oxy-Gold, and Oxy-Block product lines, as well as proprietary premixes, ingredient blends, sourcing services, and all related sales, customer service, and production processes.

This acquisition positions Rangen as an independent platform, primed to build on its legacy of performance, innovation, and customer trust. With a history of serving large and small customers alike, Rangen remains at the forefront of providing enhanced nutritional outcomes with deep expertise in Pet, Aquaculture and Livestock markets.

Mark Essig, an experienced leader with expertise across various industries, will serve as CEO of Rangen. Mark Essig has more than 30 years of senior leadership experience across multiple industries, including manufacturing, distribution, and specialty materials. Throughout his career, he has served as CEO and as a board member for both public and private companies. He is recognized for building high-performing teams, driving operational excellence, and fostering customer-focused innovation that delivers sustainable business results.

“I am honored to lead Rangen at this important inflection point in its history,” said Mark Essig. “Our legacy brands, technical expertise, and deep customer relationships provide a strong foundation. Together with Balmoral’s support, we will accelerate innovation and growth across the Pet, Aquaculture, and Livestock markets.”

Richard Levernier, board member of Rangen and Principal at Balmoral Funds, added: “Rangen has a rich history and has shown demonstrated success as a leading producer of value-added animal nutrition products. We look forward to further partnering with our customers, suppliers, employees, and all stakeholders to achieve mutually shared goals. The Company is well positioned to further invest in its business and support our customers’ growth, both with increased capacity and innovative products. We know the Rangen team feels the same way and are excited to start this next chapter.”

Balmoral’s strategic investment reaffirms its dedication to enhancing Rangen’s leadership and innovation across the animal nutrition industry. By placing a strong emphasis on employee empowerment, operational excellence, and customer and supplier relationships, Rangen is well-positioned to strengthen its leadership across the Pet, Aquaculture, and Livestock sectors. This renewed focus not only builds on the company’s trusted legacy, but also sets the stage for capturing emerging opportunities and driving long-term, sustainable growth.

Blank Rome LLP acted as legal counsel to Balmoral. Wilbur-Ellis was advised by Lazard as financial advisor and Pillsbury Winthrop Shaw Pittman LLP as legal counsel.

About Rangen

Rangen is a leading provider of animal nutrition products and services for Pet, Aquaculture and Livestock industries, serving as a critical supplier across the value chain. The Company provides high-performing antioxidants and proprietary functional ingredients, as well as services that include ingredient sourcing, materials handling, and custom-made ingredient blends to customers worldwide. Headquartered in Buhl, ID, Rangen operates 13 facilities across the United States and Canada.

About Wilbur-Ellis

Founded in 1921, the Wilbur-Ellis companies are leading marketers, distributors, and manufacturers of agricultural products and animal nutrients. By developing strong relationships, making strategic market investments, and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3.5 billion. For more information, please visit www.wilburellis.com.

About Balmoral Funds LLC

Balmoral is a Los Angeles, CA based private equity fund that was founded in 2005. Balmoral’s objective is to be the financial partner of choice for entrepreneurial and successful C-suite executives and operating advisors creating transformative outcomes in the businesses they co-invest in together. Balmoral has approximately $1.3 billion of assets under management. Balmoral typically invests in companies that have revenues between $30 to $500 million and require equity investments of $10 to $120 million, with the capability of doing more in particularly compelling opportunities.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250826716209/en/